Cybin Archives

Psychedelics News

Cybin

Industry

1 Mar 2022

An Interview With Cybin CEO Doug Drysdale

We sat down with CEO Doug Drysdale to discuss these and other industry topics, including Cybin’s developmental pipeline, upcoming clinical trials, and the state of the psychedelic medicine market...

By Jason Najum

Finance

23 Feb 2022

A Look at Recent Financial and Business Highlights

To help keep you updated, we’ve put together a summary of recent financial announcements from a variety of psychedelic medicine companies....

By Jason Najum

Breaking News, Industry

15 Feb 2022

Cybin Inks Deal w Chopra Foundation. Gets Praise From Tony Robbins

The partnership with Chopra will help the sector and in particular, Cybin, who will benefit from the association with this headline name....

By Jason Najum

Breaking News, Industry

9 Feb 2022

Cybin Granted DMT Patent for CYB004

Developing and securing intellectual property is one of the most important tasks of a psychedelic medicine firm....

By Jason Najum

Join Our Newsletter for Exclusive Updates, Stories, and More

Industry

15 Dec 2021

Cybin Nears Patent Approval for CYB004

Cybin's patent covers deuterated forms of DMT and 5-MeO-DMT, and CYB004 is looking at anxiety disorders — molecules with very interesting potential and markets with huge unmet needs....

By Jason Najum

Industry

1 Dec 2021

Cybin Gets FDA Approval For New Phase 2 Trial

Following up on their recent run of solid news (led by very positive results from their new CYB-003 compound), Cybin has just announced that the FDA has authorized a Phase...

By Jason Najum

Breaking News, Finance

12 Nov 2021

Positive Industry News for Cybin and Others Post-Wonderland

As the psychedelic medicine industry emerges from its collective post-Wonderland afterglow, we find a stream of positive industry news waiting for us on our feeds....

By Jason Najum

Industry

29 Oct 2021

Cybin Gets FDA Study Approval and Launches New Training Program

This week the company returned to our news feeds with two solid announcements....

By Jason Najum

Events

26 Oct 2021

Microdose Announces Cybin as Wonderland Private Room Sponsor

Pulling off such a massive undertaking wouldn’t be possible without the support of our sponsors, they are crucial to both the Wonderland event and the future of the psychedelic medicine...

By Microdose

Follow us on social

Latest News

AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy

Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy

Two New Studies Are Rewriting the Rules of Psychedelic Drug Development

Professional Training in Psychedelic Medicine

Psychedelic medicine is reshaping the future of mental health care. From the power of microdosing LSD to the promise of MDMA in PTSD, the world of medical psychedelics offers transformative possibilities. Our comprehensive, CE-accredited course provides you with the knowledge and understanding you need to tap into this groundbreaking field.

WordPress Ads

No Result

View All Result